WallStSmart

Varonis Systems (VRNS)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Varonis Systems generates 141% more annual revenue ($623.53M vs $258.90M). ZEPP leads profitability with a -15.5% profit margin vs -20.7%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

VRNS

Avoid

28

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.7Quality: 4.3
Piotroski: 3/9Altman Z: 0.18

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

VRNSUndervalued (+60.5%)

Margin of Safety

+60.5%

Fair Value

$66.55

Current Price

$26.50

$40.05 discount

UndervaluedFair: $66.55Overvalued
ZEPPUndervalued (+48.8%)

Margin of Safety

+48.8%

Fair Value

$46.82

Current Price

$17.47

$29.35 discount

UndervaluedFair: $46.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VRNS0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

VRNS4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
7.382/10

Expensive relative to growth rate

Return on EquityProfitability
-24.5%2/10

ROE of -24.5% — below average capital efficiency

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : VRNS

VRNS has a balanced fundamental profile.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : VRNS

The primary concerns for VRNS are EPS Growth, Piotroski F-Score, PEG Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

VRNS profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 28/100) and 43.0% revenue growth. VRNS offers better value entry with a 60.5% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Varonis Systems

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Varonis Systems (VRNS) is a prominent leader in the cybersecurity sector, offering sophisticated data security and analytics solutions that safeguard sensitive information across both on-premises and cloud infrastructures. With a strong emphasis on machine learning and behavioral analytics, Varonis enables organizations to proactively detect and mitigate potential data risks while ensuring compliance with evolving regulatory requirements. Catering to a wide array of industries, the company has established itself as an essential partner for enterprises navigating the complexities of data protection in an increasingly hostile cyber environment. As demand for comprehensive data security solutions continues to surge, Varonis stands poised for robust growth in a rapidly expanding market.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?